|
🐜
|
Variant classification in precision oncology
43 auth.
J. Leichsenring,
P. Horák,
S. Kreutzfeldt,
C. Heining,
P. Christopoulos,
A. Volckmar,
O. Neumann,
M. Kirchner,
C. Ploeger,
J. Budczies,
C. Heilig,
B. Hutter,
M. Fröhlich,
S. Uhrig,
D. Kazdal,
...
M. Allgäuer,
A. Harms,
E. Rempel,
U. Lehmann,
Michael Thomas,
N. Pfarr,
N. Azoitei,
I. Bonzheim,
R. Marienfeld,
P. Möller,
M. Werner,
F. Fend,
M. Boerries,
N. von Bubnoff,
S. Lassmann,
T. Longerich,
M. Bitzer,
T. Seufferlein,
N. Malek,
W. Weichert,
P. Schirmacher,
R. Penzel,
V. Endris,
B. Brors,
F. Klauschen,
H. Glimm,
S. Fröhling,
A. Stenzinger
|
6 |
2019 |
6
🐜
|
|
🐜
|
Spatial and temporal heterogeneity of panel-based tumor mutational burden (TMB) in pulmonary adenocarcinoma: separating biology from technical artifacts.
33 auth.
D. Kazdal,
V. Endris,
M. Allgäuer,
M. Kriegsmann,
J. Leichsenring,
A. Volckmar,
A. Harms,
M. Kirchner,
K. Kriegsmann,
O. Neumann,
R. Brandt,
S. B. Talla,
E. Rempel,
C. Ploeger,
M. von Winterfeld,
...
P. Christopoulos,
Diana M Merino,
M. Stewart,
J. Allen,
H. Bischoff,
M. Meister,
T. Muley,
F. Herth,
R. Penzel,
A. Warth,
H. Winter,
S. Fröhling,
S. Peters,
C. Swanton,
Michael Thomas,
P. Schirmacher,
J. Budczies,
A. Stenzinger
|
6 |
2019 |
6
🐜
|
|
🐜
|
Claudin-3 and Claudin-5 Protein Folding and Assembly into the Tight Junction Are Controlled by Non-conserved Residues in the Transmembrane 3 (TM3) and Extracellular Loop 2 (ECL2) Segments*
9 auth.
J. Rossa,
C. Ploeger,
Fränze Vorreiter,
T. Saleh,
J. Protze,
D. Günzel,
...
H. Wolburg,
G. Krause,
J. Piontek
|
6 |
2014 |
6
🐜
|
|
🦁
|
Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin‐6 signaling in hepatocellular carcinoma
9 auth.
C. Ploeger,
N. Waldburger,
A. Fraas,
B. Goeppert,
S. Pusch,
K. Breuhahn,
...
X. Wang,
P. Schirmacher,
S. Roessler
|
5 |
2016 |
5
🦁
|
|
🐜
|
Trailblazing Precision Medicine in Europe: a joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany.
42 auth.
A. Stenzinger,
A. Edsjö,
C. Ploeger,
M. Friedman,
S. Fröhling,
V. Wirta,
T. Seufferlein,
J. Botling,
J. Duyster,
Michael Akhras,
R. Thimme,
T. Fioretos,
M. Bitzer,
L. Cavelier,
P. Schirmacher,
...
N. Malek,
R. Rosenquist,
A. Lindstrand,
A. Wedell,
D. Gisselsson,
E. Melén,
G. Helenius,
H. Ehrencrona,
L. Engstrand,
L. Palmqvist,
L. Levin,
Lovisa Lovmar,
M. Landström,
M. Hallbeck,
M. Wadelius,
Per Sikora,
A. Beer,
A. Illert,
J. Budczies,
K. Nikolaou,
O. Kohlbacher,
P. Horák,
P. Kuhn,
C. Schroeder,
M. Boerries,
S. Lassmann,
V. Gaidzik
|
4 |
2021 |
4
🐜
|
|
🐜
|
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis
19 auth.
S. Luiken,
A. Fraas,
M. Bieg,
Raisatun N Sugiyanto,
B. Goeppert,
S. Singer,
C. Ploeger,
Gregor Warsow,
J. Marquardt,
C. Sticht,
...
C. de la Torre,
S. Pusch,
A. Mehrabi,
N. Gretz,
M. Schlesner,
R. Eils,
P. Schirmacher,
T. Longerich,
S. Roessler
|
4 |
2020 |
4
🐜
|
|
🐜
|
NTRK testing: First results of the QuiP‐EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA‐based NGS assays
24 auth.
M. Kirchner,
J. Glade,
U. Lehmann,
S. Merkelbach-Bruse,
M. Hummel,
A. Lehmann,
M. Trautmann,
J. Kumbrink,
A. Jung,
W. Dietmaier,
...
V. Endris,
Daniel Kazdal,
C. Ploeger,
M. Evert,
D. Horst,
H. Kreipe,
T. Kirchner,
E. Wardelmann,
R. Büttner,
W. Weichert,
M. Dietel,
P. Schirmacher,
A. Stenzinger,
N. Pfarr
|
4 |
2020 |
4
🐜
|
|
🐜
|
Precision cancer medicine: Concepts, current practice, and future developments
19 auth.
A. Edsjö,
Louise Holmquist,
B. Geoerger,
F. Nowak,
Georgy Gomon,
C. Alix-Panabières,
C. Ploeger,
U. Lassen,
C. le Tourneau,
J. Lehtiö,
...
P. Ott,
A. von Deimling,
S. Fröhling,
E. Voest,
Frederick Klauschen,
R. Dienstmann,
A. Alshibany,
L. Siu,
Albrecht Stenzinger
|
4 |
2023 |
4
🐜
|
